Vertigo pathophysiology: Difference between revisions

Jump to navigation Jump to search
Zehra Malik (talk | contribs)
Zehra Malik (talk | contribs)
Line 6: Line 6:


*The neurochemistry of vertigo includes 6 primary [[neurotransmitter]]s that have been identified between the 3-neuron arc that drives the [[vestibulo-ocular reflex]] (VOR). Many others play more minor roles.  
*The neurochemistry of vertigo includes 6 primary [[neurotransmitter]]s that have been identified between the 3-neuron arc that drives the [[vestibulo-ocular reflex]] (VOR). Many others play more minor roles.  
*Three neurotransmitters that work peripherally and centrally include  
*Three neurotransmitters that work peripherally and centrally include:
**[[glutamate]], [[acetylcholine]], and [[GABA]].
**[[Glutamate]] maintains the resting discharge of the central vestibular [[neurons]], and may modulate [[chemical synapse|synaptic transmission]] in all 3 neurons of the [[vestibulo-ocular reflex]] system.  
**Glutamate maintains the resting discharge of the central vestibular neurons, and may modulate [[chemical synapse|synaptic transmission]] in all 3 neurons of the VOR arc.  
**[[Acetylcholine]] appears to function as an excitatory [[neurotransmitter]].
**Acetylcholine appears to function as an excitatory neurotransmitter in both the peripheral and central synapses.  
**[[GABA]] is thought to be inhibitory for the commissures of the [[medial vestibular nucleus]], the connections between the [[cerebellar]] [[purkinje cells]] and the lateral vestibular nucleus, and the vertical VOR.  
**GABA is thought to be inhibitory for the commissures of the medial vestibular nucleus, the connections between the cerebellar [[Purkinje cells]] and the lateral vestibular nucleus, and the vertical VOR.  
*Three other neurotransmitters work centrally.  
*Three other neurotransmitters work centrally.  
**[[Dopamine]] may accelerate vestibular compensation.  
**[[Dopamine]] may accelerate vestibular compensation.  

Revision as of 18:58, 6 January 2021

Vertigo Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vertigo from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vertigo pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vertigo pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vertigo pathophysiology

CDC on Vertigo pathophysiology

Vertigo pathophysiology in the news

Blogs on Vertigo pathophysiology

Directions to Hospitals Treating Vertigo

Risk calculators and risk factors for Vertigo pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

References

Template:WH Template:WS